Benefits and harms associated with an increase in gestational diabetes diagnosis in Queensland, Australia: a retrospective cohort comparison of diagnosis rates, outcomes, interventions and medication use for two periods, 2011–2013 and 2016–2018, using a large perinatal database

Author:

Hegerty ChristopherORCID,Ostini Remo

Abstract

ObjectivesTo assess benefits and harms arising from increasing gestational diabetes (GDM) diagnosis, including for women with normal-sized babies.Design, setting and participantsDiagnosis rates, outcomes, interventions and medication use are compared in a retrospective cohort study of 229 757 women birthing in public hospitals of the Australian State of Queensland during two periods, 2011–2013 and 2016–2018, using data from the Queensland Perinatal Data Collection.Outcome measuresComparisons include hypertensive disorders, caesarean section, shoulder dystocia and associated harm, induction of labour (IOL), planned birth (PB), early planned birth <39 weeks (EPB), spontaneous labour onset with vaginal birth (SLVB) and medication use.ResultsGDM diagnosis increased from 7.8% to 14.3%. There was no improvement in shoulder dystocia associated injuries, hypertensive disorders or caesarean sections. There was an increase in IOL (21.8%–30.0%; p<0.001), PB (36.3% to 46.0%; p<0.001) and EPB (13.5%–20.6%; p<0.001), and a decrease in SLVB (56.0%–47.3%; p<0.001). Women with GDM experienced an increase in IOL (40.9%–49.8%; p<0.001), PB (62.9% to 71.8%; p<0.001) and EPB (35.3%–45.7%; p<0.001), and a decrease in SLVB (30.01%–23.6%; p<0.001), with similar changes for mothers with normal-sized babies. Of women prescribed insulin in 2016–2018, 60.4% experienced IOL, 88.5% PB, 76.4% EPB and 8.0% SLVB. Medication use increased from 41.2% to 49.4% in women with GDM, from 3.2% to 7.1% in the antenatal population overall, from 3.3% to 7.5% in women with normal-sized babies and from 2.21% to 4.38% with babies less than the 10th percentile.ConclusionOutcomes were not apparently improved with increased GDM diagnosis. The merits of increased IOL or decreased SLVB depend on the views of individual women, but categorising more pregnancies as abnormal, and exposing more babies to the potential effects of early birth, medication effects and growth limitation may be harmful.

Funder

Toowoomba Hospital Foundation

Publisher

BMJ

Subject

General Medicine

Reference92 articles.

1. Australian Institute of Health and Welfare . Incidence of gestational diabetes in Australia. Cat. no. CVD 85. Canberra: AIHW, 2019. Available: https://www.aihw.gov.au/reports/diabetes/incidence-of-gestational-diabetes-in-australia

2. Gestational diabetes mellitus ‐ management guidelines: the Australasian diabetes in pregnancy Society;Hoffman;Medical Journal of Australia,1998

3. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy

4. World Health Organization . Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. In: World health Organization. 2013. Available: https:apps.who.int/iris/handle/10665/85975

5. Nankervis A , McIntyre HD , Moses R . Ross GP et al for the Australasian diabetes in pregnancy Society. In: ADIPS Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes mellitus in Australia. 2014.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3